Literature DB >> 24328955

Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

Pablo M González1, Carlos F Lagos, Weslyn C Ward, James E Polli.   

Abstract

Bile acids (BAs) are the end products of cholesterol metabolism. One of the critical steps in their biosynthesis involves the isomerization of the 3β-hydroxyl (-OH) group on the cholestane ring to the common 3α-configuration on BAs. BAs are actively recaptured from the small intestine by the human Apical Sodium-dependent Bile Acid Transporter (hASBT) with high affinity and capacity. Previous studies have suggested that no particular hydroxyl group on BAs is critical for binding or transport by hASBT, even though 3β-hydroxylated BAs were not examined. The aim of this study was to elucidate the role of the 3α-OH group on BAs binding and translocation by hASBT. Ten 3β-hydroxylated BAs (Iso-bile acids, iBAs) were synthesized, characterized, and subjected to hASBT inhibition and uptake studies. hASBT inhibition and uptake kinetics of iBAs were compared to that of native 3α-OH BAs. Glycine conjugates of native and isomeric BAs were subjected to molecular dynamics simulations to identify topological descriptors related to binding and translocation by hASBT. Iso-BAs bound to hASBT with lower affinity and exhibited reduced translocation than their respective 3α-epimers. Kinetic data suggests that, in contrast to native BAs where hASBT binding is the rate-limiting step, iBAs transport was rate-limited by translocation and not binding. Remarkably, 7-dehydroxylated iBAs were not hASBT substrates, highlighting the critical role of 7-OH group on BA translocation by hASBT, especially for iBAs. Conformational analysis of gly-iBAs and native BAs identified topological features for optimal binding as: concave steroidal nucleus, 3-OH "on-" or below-steroidal plane, 7-OH below-plane, and 12-OH moiety toward-plane. Our results emphasize the relevance of the 3α-OH group on BAs for proper hASBT binding and transport and revealed the critical role of 7-OH group on BA translocation, particularly in the absence of a 3α-OH group. Results have implications for BA prodrug design.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24328955      PMCID: PMC4031276          DOI: 10.1021/mp400575t

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  41 in total

Review 1.  Farnesoid X receptor: from structure to potential clinical applications.

Authors:  Roberto Pellicciari; Gabriele Costantino; Stefano Fiorucci
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

2.  Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease.

Authors:  Jeffrey B Cheng; Emmanuel Jacquemin; Marie Gerhardt; Hisham Nazer; Danièle Cresteil; James E Heubi; Kenneth D R Setchell; David W Russell
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

3.  Metabolism of iso-bile acids in the rat.

Authors:  S Shefer; G Salen; S Hauser; B Dayal; A K Batta
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

4.  Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine.

Authors:  Gernot Zollner; Peter Fickert; Andrea Fuchsbichler; Dagmar Silbert; Martin Wagner; Silvia Arbeiter; Frank J Gonzalez; Hanns-Ulrich Marschall; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  J Hepatol       Date:  2003-10       Impact factor: 25.083

5.  Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids.

Authors:  Bryson W Katona; Carolyn L Cummins; Andrew D Ferguson; Tingting Li; Daniel R Schmidt; David J Mangelsdorf; Douglas F Covey
Journal:  J Med Chem       Date:  2007-10-27       Impact factor: 7.446

Review 6.  Exploitation of bile acid transport systems in prodrug design.

Authors:  Elina Sievänen
Journal:  Molecules       Date:  2007-08-16       Impact factor: 4.411

Review 7.  Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.

Authors:  A F Hofmann; L R Hagey
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

8.  Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Eric Y Zhang; Peter W Swaan
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

9.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

Authors:  Hiroyuki Sato; Antonio Macchiarulo; Charles Thomas; Antimo Gioiello; Mizuho Une; Alan F Hofmann; Régis Saladin; Kristina Schoonjans; Roberto Pellicciari; Johan Auwerx
Journal:  J Med Chem       Date:  2008-02-29       Impact factor: 7.446

10.  Human cecal bile acids: concentration and spectrum.

Authors:  James P Hamilton; Guofeng Xie; Jean-Pierre Raufman; Susan Hogan; Terrance L Griffin; Christine A Packard; Dale A Chatfield; Lee R Hagey; Joseph H Steinbach; Alan F Hofmann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-05       Impact factor: 4.052

View more
  3 in total

1.  Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.

Authors:  Stef De Lombaerde; Sara Neyt; Ken Kersemans; Jeroen Verhoeven; Lindsey Devisscher; Hans Van Vlierberghe; Christian Vanhove; Filip De Vos
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

2.  Evaluating Hepatobiliary Transport with 18F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and In Vitro and In Vivo Performance.

Authors:  Stef De Lombaerde; Ken Kersemans; Sara Neyt; Jeroen Verhoeven; Christian Vanhove; Filip De Vos
Journal:  Contrast Media Mol Imaging       Date:  2018-04-23       Impact factor: 3.161

3.  Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions.

Authors:  Alex Zaufel; Sandra M W van de Wiel; Lu Yin; Günter Fauler; Daphne Chien; Xinzhong Dong; John F Gilmer; Jennifer K Truong; Paul A Dawson; Stan F J van de Graaf; Peter Fickert; Tarek Moustafa
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-04-22       Impact factor: 5.187

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.